Sangamo Therapeutics Inc (NASDAQ:SGMO)

15.95
Delayed Data
As of 4:00pm ET
 +0.25 / +1.59%
Today’s Change
7.35
Today|||52-Week Range
27.50
-2.74%
Year-to-Date

Today’s Trading

Previous close15.70
Today’s open15.50
Day’s range15.30 - 16.15
Volume1,419,135
Average volume (3 months)2,478,448
Market cap$1.6B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+31.37%
Earnings growth (this year)+14.86%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+88.60%
P/E ratioNM
Price/Sales35.02
Price/Book7.15

Competitors

----
EPZMEpizyme Inc-0.10-0.67%
RTRXRetrophin Inc-0.31-1.08%
FPRXFive Prime Therapeut...-0.01-0.06%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateJuly 25, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$36.6M
Annual profit (last year)-$54.6M
Net profit margin-149.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
CFO, Principal Accounting Officer &
Senior VP
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts